19 nov
|
AstraZeneca
|
Barcelona
19 nov
AstraZeneca
Barcelona
Alexion, Astra Zeneca Rare Disease is seeking a Director to lead general market access, pricing, and reimbursement strategies for Haematology indications, with a focus on PNH and HSCT-TMA. The role combines strategic oversight with cross-functional collaboration across HM markets and HTA bodies.The successful candidate will shape evidence-generation plans, drive payer value narratives, and lead global pricing initiatives, while aligning with country access teams to support launches and lifecycle#J-18808-Ljbffr
📌 Global Haematology Access & Pricing Lead (Barcelona)
🏢 AstraZeneca
📍 Barcelona